Company profile
Countagen
Safety Assessment of Genome Editing | LockSeq Off-Target Confirmation
- Industry
- Biotechnology Research
- Employees
- 6
- Headquarters
- Stockholm
- Founded
- 2020
- Office locations
- 1
Countagen company summary
Countagen is a company in the Biotechnology Research industry, headquartered in Stockholm, founded in 2020. On LinkedIn the company has around 6 employees.
What technology does Countagen use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Countagen
Countagen is a Stockholm-based biotechnology company committed to accelerating the pace of gene editing advancements by providing high-resolution gene editing characterization. Out technology platform, LockSeq, is a novel targeted NGS library preparation based on a unique gap-fill chemistry that minimizes target dropouts and amplification bias, enabling routine and standardized gene editing characterization at every stage of development. The LockSeq Advantage: - Simultaneous Indel Profiling: Profile and validate hundreds of genomic loci in a single reaction. - High Sensitivity: Robust detection of on- and off-target edits down to 0.1% frequency. - Broad Compatibility: Compatibility across sequencing platforms. - Cost-Efficient Scalability: Scale panels and samples with minimal target dropout and uniform target capture. 📍 Based in the SciLifeLab / Karolinska Institutet ecosystem, Solna.
Where is Countagen located?
Countagen lists 1 location.
Compare companies similar to Countagen
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Countagen countagen.com | Biotechnology Research | 6 | 2020 | Stockholm |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Countagen
What does Countagen do?
Countagen is a Stockholm-based biotechnology company committed to accelerating the pace of gene editing advancements by providing high-resolution gene editing characterization. Out technology platform, LockSeq, is a novel targeted NGS library preparation based on a unique gap-fill chemistry that minimizes target dropouts and amplification bias, enabling routine and standardized gene editing characterization at every stage of development. The LockSeq Advantage: - Simultaneous Indel Profiling: Profile and validate hundreds of genomic loci in a single reaction. - High Sensitivity: Robust detection of on- and off-target edits down to 0.1% frequency. - Broad Compatibility: Compatibility across sequencing platforms. - Cost-Efficient Scalability: Scale panels and samples with minimal target dropout and uniform target capture. 📍 Based in the SciLifeLab / Karolinska Institutet ecosystem, Solna.
How many employees does Countagen have?
Countagen has around 6 employees on LinkedIn.
Where is Countagen headquartered?
Countagen is headquartered in Stockholm.
When was Countagen founded?
Countagen was founded in 2020.
Build a lead list from companies like Countagen
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.